Horizon Therapeutics
| Use attributes for filter ! | |
| Stock price | HZNP |
|---|---|
| Disclaimer | |
| Headquarters | Dublin 4 |
| Ceo | Timothy P Walbert |
| Revenue | 1. 056 billion USD (2017) |
| Subsidiaries | Horizon Pharma USA, Inc. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046033 |
About Horizon Therapeutics
Horizon Therapeutics plc is an Irish–tax registered pharmaceutical company that acquires, rebrands, repackages, and reprices specialist drugs for sale into the U. S. healthcare system, which represented 97% of Horizon's 2017 worldwide sales.
